Entrada Therapeutics Reports Phase 1/2 Data for ENTR-601-45 in DMD Exon 45 Skipping

Psychedelic Clinical Trials PSYCH PULSE Real-World ... press release is furnished as an exhibit rather than summarized in the filing itself.

Share this story

Surfaced by this Google Alert